Market Place
Sourcing Support
Organicell Starts Enrolling Long COVID Trial
17 Nov 2022 //
ACCESSWIRE
Organicell Regenerative Medicine Announces Expansion of Management Team
20 Sep 2022 //
FIRSTWORLDPHARMA
Organicell Regenerative Medicine, Inc. Announces Expansion of Management Team
20 Sep 2022 //
ACCESSWIRE
Organicell Regenerative Medicine, Inc. Announces Expansion into Health
16 Sep 2022 //
ACCESSWIRE
Organicell secures Additional $11 Mil in Financing for Trial Enrollment
09 Sep 2022 //
FIRSTWORLDPHARMA
Organicell Announces Results of Their Expanded Access Trial of ZofinTM
15 Jun 2021 //
BUSINESSWIRE
Organicell Launches Autologous Blood Derived Platform PPX™ – Patient Pure X™
09 Jun 2021 //
BUSINESSWIRE
Organicell To Present Results Of Zofin™ Clinical Studies At The International
25 May 2021 //
BUSINESSWIRE
Organicell Signs an Exclusive Distribution Agreement with Apex Services
18 May 2021 //
BUSINESSWIRE
Organicell Receives Approval in Pakistan for the Use of Zofin™
11 May 2021 //
BUSINESSWIRE
Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial
28 Apr 2021 //
BUSINESSWIRE
Organicell Completes Enrollment for its Expanded Trial to Treat COVID-19 Zofin™
22 Apr 2021 //
BUSINESSWIRE
Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19
21 Apr 2021 //
BUSINESSWIRE
Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™
21 Apr 2021 //
BUSINESSWIRE
Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™
14 Apr 2021 //
BIOSPACE
Organicell & The Centers for Disease Control and Prevention Enter Into Agreement
23 Mar 2021 //
BUSINESSWIRE
Organicell and The Centers for Disease Control and Prevention
23 Mar 2021 //
BUSINESSWIRE
‘Frontiers in Medicine’ Publishes Organicell’s Case Report on Use of Zofin
18 Mar 2021 //
BUSINESSWIRE
Organicell Announces FDA Approval of IND for the Use of Zofin™ (COPD)
28 Jan 2021 //
BUSINESSWIRE
Organicell Regenerative Medicine and Its Investigational Therapeutic Zofin™
29 Dec 2020 //
BUSINESSWIRE
Organicell Regenerative Medicine and Its Investigational Therapeutic Zofin™
29 Dec 2020 //
BUSINESSWIRE
Organicell Partners with Regenerative Care Network to Study Potential of Zofin™
20 Oct 2020 //
GLOBENEWSWIRE
FDA Grants Organicell Expanded Access to Treat COVID-19 Patients with Zofin™
29 Sep 2020 //
BUSINESSWIRE
Three New COVID-19 Patients Treated with Zofin™ Report Improvement
02 Sep 2020 //
BUSINESSWIRE
Organicell Phase I/II Clinical Trial Update
18 Aug 2020 //
GLOBENEWSWIRE
Organicell Reports Positive Results from Compassionate Use of Organicell Flow
27 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.